Resonance Health

Resonance Health Net Income

The Net Income of Resonance Health (RHT.AX) as of Oct 24, 2026 is 1.51 M AUD. In the previous year, Net Income was -1.73 M AUD — a change of -187.31% (higher).

Net Income

1.51 MAUD

YoY

-187.31%

Last updated:

In 2026, Resonance Health's profit amounted to 1.51 M AUD, a -187.31% increase from the -1.73 M AUD profit recorded in the previous year.

The Resonance Health Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Income
Date
Net Income
Jan 1, 2019
1.27 M AUD
Jan 1, 2020
-715,000.00 AUD
Jan 1, 2021
585,858.00 AUD
Jan 1, 2022
-1.14 M AUD
Jan 1, 2023
-780,000.00 AUD
Jan 1, 2024
169,303.00 AUD
Jan 1, 2025
-1.73 M AUD
Jan 1, 2026
1.51 M AUD
The Resonance Health Net Income history
YEARNet IncomeYoY
1.51 MAUD-187.31%
-1.73 MAUD-1,123.57%
169,303.00AUD-121.71%
-780,000.00AUD-31.70%
-1.14 MAUD-294.93%
585,858.00AUD-181.94%
-715,000.00AUD-156.30%
1.27 MAUD+465.40%
224,619.00AUD-173.89%
-304,000.00AUD-20.83%
-384,000.00AUD-182.90%
463,234.00AUD-739.69%
-72,415.00AUD-64.50%
-204,000.00AUD-24.16%
-269,000.00AUD-15.14%
-317,000.00AUD+210.78%
-102,000.00AUD-116.53%
617,051.00AUD-1,590.75%
-41,392.00AUD-94.29%
-725,000.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Resonance Health Revenue

Resonance Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
3.67 M AUD
-1.18 M AUD
-715,000.00 AUD
Jan 1, 2021
3.78 M AUD
188,190.00 AUD
585,858.00 AUD
Jan 1, 2022
3.83 M AUD
-1.77 M AUD
-1.14 M AUD
Jan 1, 2023
4.40 M AUD
-1.62 M AUD
-780,000.00 AUD
Jan 1, 2024
8.59 M AUD
-879,000.00 AUD
169,303.00 AUD
Jan 1, 2025
11.07 M AUD
-1.93 M AUD
-1.73 M AUD
Jan 1, 2026
15.75 M AUD
1.53 M AUD
1.51 M AUD
Jan 1, 2027 (e)
0.00 AUD
0.00 AUD
0.00 AUD

Resonance Health Margins

Resonance Health stock margins

The Resonance Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Resonance Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Resonance Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
100.00 %
-32.17 %
-19.49 %
Jan 1, 2021
100.00 %
4.98 %
15.50 %
Jan 1, 2022
100.00 %
-46.29 %
-29.83 %
Jan 1, 2023
100.00 %
-36.89 %
-17.71 %
Jan 1, 2024
100.00 %
-10.23 %
1.97 %
Jan 1, 2025
100.00 %
-17.42 %
-15.65 %
Jan 1, 2026
93.95 %
9.72 %
9.61 %
Jan 1, 2027 (e)
93.95 %
0.00 %
0.00 %

Resonance Health Stock analysis

What does Resonance Health do? Resonance Health Ltd is an Australian company that operates in the medical technology industry. The company's business model is to offer groundbreaking solutions for the diagnosis and treatment of liver and iron diseases. As a pioneering company in the development of methods and technologies for quantifying liver and iron concentrations, Resonance Health continually sets new standards in the industry. The company was founded in 2000 by a team of biomedicine professionals from the University of Western Australia. Over the years, the company has gained a lot of experience and constantly evolved to keep up with the progress of medical technology. The goal is to provide patients with better treatment and improved quality of life. One division of the company is the development and manufacturing of diagnostic tools for quantifying liver and iron diseases such as hepatitis, fatty liver, or hemochromatosis. The quantification method used by Resonance Health is called FerriScan. This method is non-invasive and painless, using magnetic resonance imaging (MRI) to measure the concentration of iron in the tissue. This is particularly important as a change in iron content can indicate a progressing liver disease. In addition to the FerriScan diagnostic tool, Resonance Health also offers a software package for analyzing FerriScan results, which is used by physicians and clinicians to assess disease progression. Furthermore, the company also develops solutions in the field of hemochromatosis, a genetic disorder that can lead to increased iron levels in the body. Another division of Resonance Health is the provision of research and development services to further develop and improve FerriScan and other technologies. The company collaborates with other companies, scientific institutions, and universities to advance the current developments in liver and iron diagnostics. Resonance Health has a range of products that contribute to better diagnosis and treatment of liver and iron diseases. These include FerriScan, the FerriSmart software package for precise monitoring of iron and liver health, and Hepatica, a software supporting hospitals and clinics in the diagnosis of liver diseases. The company is an innovative leader in the industry, contributing to improving the quality of life for patients. The products and services of Resonance Health have helped doctors and clinicians to effectively treat and diagnose liver and iron diseases. Additionally, the company has established a strong scientific foundation and works closely with leading institutions to continuously develop innovative solutions. Resonance Health is a company with a rich history that continues to evolve to meet the demands of the medical technology industry. The company aims to continuously improve the diagnosis and treatment of liver and iron diseases and offer better solutions. Resonance Health is one of the most popular companies on Eulerpool.

Net Income Details

Understanding Resonance Health's Profit Margins

The profit margins of Resonance Health represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Resonance Health's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Resonance Health's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Resonance Health's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Resonance Health’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Resonance Health stock

Net Income of Resonance Health is 1.51 M AUD in 2026.

Net Income of Resonance Health changed from -1.73 M AUD to 1.51 M AUD, representing a -187.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Income Resonance Health since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's Resonance Health historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Resonance Health

All Key Metrics — Resonance Health